Sandia Holdings, LLC - CASCADIAN THERAPEUTICS INC ownership

CASCADIAN THERAPEUTICS INC's ticker is CASC and the CUSIP is 14740B606. A total of 78 filers reported holding CASCADIAN THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.

Quarter-by-quarter ownership
Sandia Holdings, LLC ownership history of CASCADIAN THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$3,431,000
-9.5%
927,2640.0%1.56%
-3.9%
Q3 2017$3,793,000
+10.1%
927,2640.0%1.63%
+1.4%
Q2 2017$3,445,000
+53.0%
927,264
+70.5%
1.61%
+41.7%
Q1 2017$2,251,000
-3.9%
543,7190.0%1.13%
-10.5%
Q4 2016$2,343,000543,7191.27%
Other shareholders
CASCADIAN THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Abingworth LLP 925,000$3,783,0002.62%
EcoR1 Capital, LLC 3,000,000$12,270,0001.64%
BVF INC/IL 3,133,224$12,815,0001.63%
Sandia Holdings, LLC 927,264$3,793,0001.63%
NEA Management Company, LLC 9,064,575$37,074,0001.30%
P.A.W. CAPITAL CORP 240,000$982,0001.03%
FT Options LLC 115,206$471,0000.71%
Avoro Capital Advisors LLC 1,821,248$7,449,0000.58%
Baupost Group 8,721,079$35,669,0000.44%
SPHERA FUNDS MANAGEMENT LTD. 681,210$2,786,0000.40%
View complete list of CASCADIAN THERAPEUTICS INC shareholders